Novartis Aktie
99,16
EUR
-0,20
EUR
-0,20
%
92,73
CHF
-0,95
CHF
-1,01
%
Werbung
Novartis Aktie Analyse
31.05.12 | Novartis buy | Deutsche Bank AG | |
30.05.12 | Novartis outperform | Credit Suisse Group | |
29.05.12 | Novartis buy | UBS AG | |
29.05.12 | Novartis buy | UBS AG | |
17.05.12 | Novartis buy | Société Générale Group S.A. (SG) | |
10.05.12 | Novartis buy | Société Générale Group S.A. (SG) | |
04.05.12 | Novartis buy | UBS AG | |
26.04.12 | Novartis outperform | Sanford C. Bernstein and Co., Inc. | |
Werbung
|
|||
25.04.12 | Novartis kaufen | Hamburger Sparkasse AG (Haspa) | |
24.04.12 | Novartis buy | WestLB AG | |
24.04.12 | Novartis buy | Sarasin Research | |
23.04.12 | Novartis buy | Nomura | |
23.04.12 | Novartis buy | Sarasin Research | |
11.04.12 | Novartis buy | UBS AG | |
02.04.12 | Novartis buy | Sarasin Research | |
27.03.12 | Novartis outperform | Sanford C. Bernstein and Co., Inc. | |
21.03.12 | Novartis buy | Deutsche Bank AG | |
16.03.12 | Novartis buy | Sarasin Research | |
09.03.12 | Novartis buy | UBS AG | |
30.01.12 | Novartis kaufen | Hamburger Sparkasse AG (Haspa) | |
27.01.12 | Novartis outperform | Credit Suisse Group | |
27.01.12 | Novartis buy | Société Générale Group S.A. (SG) | |
25.01.12 | Novartis buy | WestLB AG | |
25.01.12 | Novartis buy | Sarasin Research | |
24.01.12 | Novartis buy | Sarasin Research | |
24.01.12 | Novartis outperform | Sanford C. Bernstein and Co., Inc. | |
23.01.12 | Novartis buy | Nomura | |
20.01.12 | Novartis buy | Nomura | |
19.01.12 | Novartis overweight | J.P. Morgan Cazenove | |
17.01.12 | Novartis buy | Nomura | |
16.01.12 | Novartis buy | WestLB AG | |
13.01.12 | Novartis buy | Sarasin Research | |
12.01.12 | Novartis buy | Nomura | |
09.01.12 | Novartis kaufen | Hamburger Sparkasse AG (Haspa) | |
09.01.12 | Novartis outperform | Sanford C. Bernstein and Co., Inc. | |
05.01.12 | Novartis overweight | J.P. Morgan Cazenove | |
04.01.12 | Novartis buy | Deutsche Bank AG | |
27.12.11 | Novartis kaufen | Raiffeisen Centrobank AG | |
21.12.11 | Novartis overweight | J.P. Morgan Cazenove | |
16.12.11 | Novartis outperform | Credit Suisse Group | |
14.12.11 | Novartis overweight | J.P. Morgan Cazenove | |
13.12.11 | Novartis buy | WestLB AG | |
13.12.11 | Novartis outperform | Credit Suisse Group | |
03.11.11 | Novartis buy | Deutsche Bank AG | |
27.10.11 | Novartis buy | Nomura | |
27.10.11 | Novartis buy | Citigroup Corp. | |
26.10.11 | Novartis outperform | Credit Suisse Group | |
26.10.11 | Novartis kaufen | Hamburger Sparkasse AG (Haspa) | |
19.10.11 | Novartis outperform | Credit Suisse Group | |
19.10.11 | Novartis kaufen | Independent Research GmbH |
Werbung
Werbung